3-IMINO-N1,N1,N2,N2-TETRAISOPROPYLCYCLOPROP-1-ENE-1,2-DIAMINE, 90.0%, 500mg

1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 95.0%, 10g

1,3-Dimethyl-2-imidazolidinone>99.0%(GC)100mL

3-(Chloromethyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine, 98%, 250mg

Glycine, 25 kg

2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)-, 98%, 25mg

5-Fluoro-2,3-dihydrobenzo[b][1,4]dioxine, 96%, 100mg

(R)-3-(((9H-Fluoren-9-yl)methyl)thio)-2-(((allyloxy)carbonyl)amino)propanoic acid, 97%, 1g

Dimethyl 5-(allyloxy)isophthalate, 98%, 1g

2-Chloro-5-(propan-2-yl)-1,3-thiazole-4-carboxylic acid, 95%, 2.5g

(2R,5R)-5-benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one, 97%, 1g

Sodium hypochlorite solution, 12% Cl, 2.5 L, plastic bag.

Hafnium(IV) Trifluoromethanesulfonate>90.0%(T)1g